Teclistamab salvage therapy for multiple myeloma relapse after allogeneic hemopoietic stem cell transplant: A case report

Am J Hematol. 2024 Jan;99(1):E29-E31. doi: 10.1002/ajh.27159. Epub 2023 Nov 30.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Multiple Myeloma* / drug therapy
  • Neoplasm Recurrence, Local
  • Salvage Therapy
  • Transplantation, Autologous

Substances

  • Antineoplastic Agents